Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail
-

Lotrisone (clotrimazole and betamethasone dipropionate) Cream and Lotion


Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- January 2008

 

The detailed view includes drug products with safety labeling changes to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, or PATIENT PACKAGE INSERT/MEDICATION GUIDE sections. Deletions or editorial revisions made to these sections are not included in this summary.


Summary View

Sections Modified

ADVERSE REACTIONS

  • The following local adverse reactions have been reported with topical corticosteroids and may occur more frequently with the use of occlusive dressings...
    • ...capillary fragility (ecchymoses), and sensitization (local reactions upon repeated application of product)...

PATIENT PACKAGE INSERT

  • What are the possible side effects of Lotrisone Cream and Lotion?
    • ...fragile blood vessels, sensitization (local reactions upon repeated application of product)...
-
-